JPRN-UMIN000012928已完成3 期
Clinical Evaluation of New Terumo drug elUting coRonary stent system in the treatment of patients with coronarY artery disease in Small Vessels in Japanese population - CENTURY JSV Trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Not a suitable candidate for DAPT, 2.Known allergy to Limus family drugs, cobalt, chromium, nickel, or contrast agent, 3.Most recent LVEF of the patient is not more than 25%, 4.PLT count is less than 100K cells/mm3 or more than 700K cells/mm3, 5.WBC count is less than 3,500 cells/mm3, 6.Cerebral hemorrhage within 180 days prior to the baseline procedure, 7.Active peptic ulcer or upper GI bleeding within 180 days prior to the baseline procedure, 8.Bleeding diathesis or coagulopathy, 9.Any planned future PCI, 10.Currently participating in an investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the current study endpoints, 11. In the investigator's opinion, patient has (a) co-morbid conditions(s) that could limit patients's abilibility to participate in the study, compliance with FU requiements or impact the scientific integrity of the study, 12. In cardiogenic shock, 13.Life expectancy less than 1 year, 14. Renal failure requiring dialysis, 15. Female of child-bearing potential, 16.AMI within 48 hours before baseline procedure, 17.Previous PCI with stenting (within 30 days), 18.Previous stenting within the target lesion, 19.Will refuse a blood transfusion, 20.A widespread peripheral vascular disease that would interfere with vascular access, 21.The target lesion and non-target lesion(s) has any of the following characteristics, a)Bifurcation lesion that need stenting of main and side branch, b)Ostial lesion involving the origin of the coronary artery within the first 3 mm, c) Located in or supplied by an arterial or venous bypass graft, d) Require vessel preparation other than balloon-predilatation, e) Left main trunk, f)Chronic total occlusion, 22. There are three or more non-target lesions other than one target lesion. 23.A non-target lesion is located within 15 mm visually from a target lesion. 24. The non-target lesion that need more than 1 stent.
研究者
相似试验
已完成
3 期
CLINICAL EVALUATION OF NEW TERUMO DRUG ELUTING CORONARY STENT SYSTEM IN THE TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASEIschemic heart diseaseJPRN-UMIN000006940Terumo Europe N.V.1,120
已完成
2 期
CLINICAL EVALUATION OF NEW TERUMO DRUG ELUTING CORONARY STENT SYSTEM IN THE TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASEIschemic heart diseaseJPRN-UMIN000006575Terumo Europe N.V.100
已完成
不适用
Exporatory clinical study for newly developed drug therapy for preeclampsia with oral nicotinamidepreeclampsiaJPRN-UMIN000029418Tohoku University6
已完成
不适用
Study of the therapy using ketamine in refractory depressiorefractory depressive disorderdepression, anxiety, anhedoneaD003865JPRN-jRCTs051210192Murai Toshiya10
进行中（未招募）
不适用
An efficacy, safety and pharmacokinetic study on the short-term and long-term use of METFORMIN in obese children and adolescentsobese children and adolescents of Caucasian descent with insulin resistance in the age of = 10 and = 16 years at study entry.EUCTR2010-023980-17-NLSt. Antonius Hospital